TORONTO--(BUSINESS WIRE)--Apollo Healthcare Corp. (TSX: AHC, OTC QX: AHCCF) (“Apollo” or the “Company”) today announced financial results for the third quarter ended September 30, 2021.
The Company’s unaudited interim financial statements for the three and nine months ended September 30, 2021, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at www.sedar.com. All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated.
Highlights
- Revenues were $31.5 million and $115.4 million and EBITDA was $5 million and $31.8 million for the three and nine month periods ended September 30, 2021, respectively.
- The Company is debt free, had cash on hand of $35.2 million at September 30, 2021 and has access to a $50 million revolving facility from its commercial bank.
- On November 5, 2021, the Company announced it had entered into an arrangement agreement pursuant to which it would be acquired by Anjac SAS. Please refer to the Company’s press release dated November 5, 2021 which may be found at www.sedar.com for additional details.
Please refer to the Company’s Management’s Discussion and Analysis (which may be found on www.sedar.com) for additional detail and discussion regarding the Company’s results from operations.
https://www.businesswire.com/news/home/20211112005725/en/